1. Home
  2. TLSI vs MDIA Comparison

TLSI vs MDIA Comparison

Compare TLSI & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • MDIA
  • Stock Information
  • Founded
  • TLSI 2010
  • MDIA 2019
  • Country
  • TLSI United States
  • MDIA United States
  • Employees
  • TLSI N/A
  • MDIA N/A
  • Industry
  • TLSI Medical Specialities
  • MDIA Broadcasting
  • Sector
  • TLSI Health Care
  • MDIA Consumer Discretionary
  • Exchange
  • TLSI Nasdaq
  • MDIA Nasdaq
  • Market Cap
  • TLSI 166.8M
  • MDIA 163.9M
  • IPO Year
  • TLSI N/A
  • MDIA N/A
  • Fundamental
  • Price
  • TLSI $5.00
  • MDIA $3.80
  • Analyst Decision
  • TLSI Strong Buy
  • MDIA
  • Analyst Count
  • TLSI 2
  • MDIA 0
  • Target Price
  • TLSI $14.00
  • MDIA N/A
  • AVG Volume (30 Days)
  • TLSI 64.0K
  • MDIA 44.3K
  • Earning Date
  • TLSI 08-14-2024
  • MDIA 09-13-2024
  • Dividend Yield
  • TLSI N/A
  • MDIA N/A
  • EPS Growth
  • TLSI N/A
  • MDIA N/A
  • EPS
  • TLSI N/A
  • MDIA N/A
  • Revenue
  • TLSI $24,736,000.00
  • MDIA $31,762,000.00
  • Revenue This Year
  • TLSI $61.24
  • MDIA N/A
  • Revenue Next Year
  • TLSI $47.32
  • MDIA N/A
  • P/E Ratio
  • TLSI N/A
  • MDIA N/A
  • Revenue Growth
  • TLSI 67.75
  • MDIA N/A
  • 52 Week Low
  • TLSI $3.32
  • MDIA $0.40
  • 52 Week High
  • TLSI $10.42
  • MDIA $6.86
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 38.30
  • MDIA 52.59
  • Support Level
  • TLSI $4.80
  • MDIA $3.32
  • Resistance Level
  • TLSI $5.47
  • MDIA $3.44
  • Average True Range (ATR)
  • TLSI 0.33
  • MDIA 0.34
  • MACD
  • TLSI -0.05
  • MDIA -0.04
  • Stochastic Oscillator
  • TLSI 16.82
  • MDIA 46.83

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About MDIA Mediaco Holding Inc.

MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.

Share on Social Networks: